Pharmaceutical / Drug Definition :
Inhibits PDE5, enhancing the effects of nitric oxide released during sexual stimulation. This action inactivates cyclic guanosine monophosphate (cGMP), which then increases cGMP levels in corpus cavernosum. Resulting smooth muscle relaxation promotes increased blood flow and subsequent erection
FDA Label Requirements and Exceptions
Sildenafil Citrate
FDA Import Information
Sildenafil Citrate
FDA Detentions
Sildenafil Citrate (Sildenafil Citrate Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Sildenafil Citrate (Sildenafil Citrate Suppliers)
- Processors Sildenafil Citrate
- Repackers Sildenafil Citrate
- Relabelers Sildenafil Citrate
- Exporters Sildenafil Citrate
- Importers Sildenafil Citrate
For more information about Sildenafil Citrate, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
